Patents by Inventor Lester John Lloyd

Lester John Lloyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9408538
    Abstract: The present invention pertains to a method and apparatus for pressure sore detection. A modulated optical signal based on a digital code sequence is transmitted to human tissue. A temporal transfer characteristic is derived from the modulated optical signal. Tissue characteristics is determined based on the temporal transfer characteristic.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: August 9, 2016
    Assignees: Triple Ring Technologies, Inc., Ocela Technologies, Inc.
    Inventors: Lester John Lloyd, Kate Leeann Bechtel, Joseph Anthony Heanue, Brian Patrick Wilfley
  • Patent number: 9398870
    Abstract: A system includes an enclosure having a processor and a memory coupled to the processor. The enclosure includes a display coupled to the processor where the display is visible from an exterior of the enclosure; and a battery within the enclosure coupled to the processor and the display. The enclosure includes a probe tip coupled to an exterior of the enclosure. The probe tip includes first, second, and third sensor openings. A first distance between the first and second sensor openings is different than a second distance between the first and third sensor openings. The enclosure includes code stored in the memory where the code is executable by the processor, and includes code to receive first data associated with the first and second sensor openings, code to receive second data associated with the first and second sensor openings, and code to perform SRS using the first and the second data.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: July 26, 2016
    Assignee: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, Joseph Heanue, Lester John Lloyd, Edward Solomon
  • Patent number: 9392978
    Abstract: An intraoperative tissue oximetry device includes a tissue marker that includes one or more pens or one or more similar ink sources, such that the tissue marker can mark tissue according to oxygen saturation measurements made by the tissue oximetry device, thereby visually delineating regions of potentially viable tissue from regions of potentially nonviable tissue.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: July 19, 2016
    Assignee: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, Joseph Anthony Heanue, Lester John Lloyd
  • Publication number: 20160100781
    Abstract: A tissue oximetry device utilizes at least three or at least four different wavelengths of light for collection of reflectance data where the different wavelengths are longer than 730 nanometers. The three or four wavelengths are utilized to generate a range of reflectance data suited for accurate determination of oxygenated hemoglobin and deoxygenated hemoglobin concentrations. The relatively long wavelengths decrease optical interference from certain dyes, particularly methylene blue and PVPI, which may be present on tissue being analyzed for viability and further enhance the generation of accurate reflectance data. The wavelengths are 760 nanometers, 810 nanometers, and 850 nanometers, or 760 nanometers, 810 nanometers, 850 nanometers, and 900 nanometers.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 14, 2016
    Inventors: Kate LeeAnn Bechtel, Lester John Lloyd
  • Patent number: 9216000
    Abstract: A tissue oximetry device utilizes at least three or at least four different wavelengths of light for collection of reflectance data where the different wavelengths are longer than 730 nanometers. The three or four wavelengths are utilized to generate a range of reflectance data suited for accurate determination of oxygenated hemoglobin and deoxygenated hemoglobin concentrations. The relatively long wavelengths decrease optical interference from certain dyes, particularly methylene blue and PVPI, which may be present on tissue being analyzed for viability and further enhance the generation of accurate reflectance data. The wavelengths are 760 nanometers, 810 nanometers, and 850 nanometers, or 760 nanometers, 810 nanometers, 850 nanometers, and 900 nanometers.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: December 22, 2015
    Assignee: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, Lester John Lloyd
  • Patent number: 9131844
    Abstract: The present invention pertains to a method and apparatus for pressure sore detection. A modulated optical signal based on a digital code sequence is transmitted to human tissue. A temporal transfer characteristic is derived from the modulated optical signal. Tissue characteristics is determined based on the temporal transfer characteristic.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: September 15, 2015
    Assignee: Triple Ring Technologies, Inc.
    Inventors: Joseph Anthony Heanue, Lester John Lloyd, Kate Leeann Bechtel, Brian Patrick Wilfley
  • Publication number: 20140266791
    Abstract: The programmable monitoring system comprises one or more motion sensors, one or more temperature sensors, one or more door sensors and one or more pill box sensors. Each sensor is tagged with a unique code readable by a smart phone camera and software program which allows alarms on the smart phone to be set. The alarms are individually set for any or all of the sensors based on habits of the person being monitored.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: ALCHERA INCORPORATED D/B/A SERVANDUS
    Inventors: LESTER JOHN LLOYD, TIMOTHY PATRICK LLOYD, LAUREN FELIX YAZOLINO
  • Publication number: 20140046152
    Abstract: A system includes an enclosure having a processor and a memory coupled to the processor. The enclosure includes a display coupled to the processor where the display is visible from an exterior of the enclosure; and a battery within the enclosure coupled to the processor and the display. The enclosure includes a probe tip coupled to an exterior of the enclosure. The probe tip includes first, second, and third sensor openings. A first distance between the first and second sensor openings is different than a second distance between the first and third sensor openings. The enclosure includes code stored in the memory where the code is executable by the processor, and includes code to receive first data associated with the first and second sensor openings, code to receive second data associated with the first and second sensor openings, and code to perform SRS using the first and the second data.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, Joseph Heanue, Lester John Lloyd, Edward Solomon
  • Publication number: 20130035569
    Abstract: The present invention pertains to a method and apparatus for hemometry in humans. Pressure is applied proximal to a target area in human tissue. A modulated optical signal based on a digital code sequence is transmitted to the target area. A temporal transfer characteristic is derived from the modulated optical signal. Concentration of an analyte is determined based on the temporal transfer characteristic.
    Type: Application
    Filed: July 16, 2012
    Publication date: February 7, 2013
    Applicant: NELLCOR PURITAN BENNETT LLC
    Inventors: Joseph Anthony Heanue, Lester John Lloyd, Kate Leeann Bechtel, Brian Patrick Wilfley, John Frederick Heanue
  • Patent number: 8308673
    Abstract: Methods and devices for selectively removing an agent from a physiological site, e.g., a physiological efferent fluid collection site, are provided. Aspects of the invention include fluid removal (e.g., aspiration) devices having a fluid removal element and a flow modulator positioned at a distal end of the fluid removal element. The flow modulator is configured to converge intersecting fluid flow paths into the fluid removal element. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: November 13, 2012
    Assignee: Catharos Medical Systems, Inc.
    Inventors: Ali Hassan, Lester John Lloyd, Michael Orth, Mark Yang, Binh Luong, Brian K. Courtney, Peter J. Fitzgerald
  • Publication number: 20120130257
    Abstract: The present invention pertains to a method and apparatus for pressure sore detection. A modulated optical signal based on a digital code sequence is transmitted to human tissue. A temporal transfer characteristic is derived from the modulated optical signal. Tissue characteristics is determined based on the temporal transfer characteristic.
    Type: Application
    Filed: February 1, 2012
    Publication date: May 24, 2012
    Inventors: Joseph Anthony HEANUE, Lester John LLOYD, Kate Leeann BECHTEL, Brian Patrick WILFLEY
  • Publication number: 20110118575
    Abstract: The present invention pertains to a method and apparatus for pressure sore detection. A modulated optical signal based on a digital code sequence is transmitted to human tissue. A temporal transfer characteristic is derived from the modulated optical signal. Tissue characteristics is determined based on the temporal transfer characteristic.
    Type: Application
    Filed: January 21, 2011
    Publication date: May 19, 2011
    Inventors: LESTER JOHN LLOYD, KATE LEEANN BECHTEL, JOSEPH ANTHONY HEANUE, BRIAN PATRICK WILFLEY
  • Publication number: 20090048552
    Abstract: Methods and devices for selectively removing an agent from a physiological site, e.g., a physiological efferent fluid collection site, are provided. Aspects of the invention include fluid removal (e.g., aspiration) devices having a fluid removal element and a flow modulator positioned at a distal end of the fluid removal element. The flow modulator is configured to converge intersecting fluid flow paths into the fluid removal element. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites.
    Type: Application
    Filed: June 12, 2008
    Publication date: February 19, 2009
    Inventors: ALI HASSAN, Lester John Lloyd, Michael Orth, Mark Yang, Binh Luong, Brian K. Courtney, Peter J. Fitzgerald
  • Patent number: 6409662
    Abstract: A patient interface system for collecting and transferring data from a patient to a remote monitoring system, as well as methods for its use, are provided. The subject system comprises: (a) a data collection means comprising an edema sensing means and an interrogation means; (b) a processing means for processing the collected data; and (c) a communication means for transferring said collected data from said interface means to a remote monitoring system and receiving instructional data from a remote monitoring system. The subject system finds use in the remote monitoring of a variety of conditions, particularly in the remote monitoring of cardiac associated diseases.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: June 25, 2002
    Assignee: Alere Medical, Inc.
    Inventors: Lester John Lloyd, Melissa Ann Prince
  • Patent number: 6186962
    Abstract: Methods and devices are provided for detecting the presence of edema in a mammalian host. In the subject methods, a device comprising a planar surface and a probe extendable therefrom is contacted with the surface of the extremity. The probe is then extended from the planar surface in a manner sufficient to form a depression or “pit” in the skin surface of the extremity. The probe is then held in constant position relative to the planar surface and the extremity for a period of time during which a plurality of force measurements and a force profile is generated therefrom. The force profile is then related to the presence of edema in the patient. The subject methods find use in the diagnosis and management of diseases characterized by the presence of edema as a physical manifestation, particularly congestive heart failure.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: February 13, 2001
    Assignee: Alere Incorporated
    Inventors: Lester John Lloyd, Jorah Wyer
  • Patent number: 6123068
    Abstract: A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: September 26, 2000
    Assignee: Aradigm Corporation
    Inventors: Lester John Lloyd, Peter M. Lloyd, Reid M. Rubsamen, Jeffrey Arthur Schuster
  • Patent number: 6080106
    Abstract: A patient interface system for collecting and transferring data from a patient to a remote monitoring system, as well as methods for its use, are provided. The subject system uses: (a) a data collection device with a sensor and an interrogation device; (b) a processing device for processing the collected data; and (c) a communication device for transferring said collected data from the interface system to a remote monitoring system and receiving instructional data from a remote monitoring system. The subject system finds use in the remote monitoring of a variety of conditions, particularly in the remote monitoring of cardiac associated diseases. In addition, the sensor is a scale either programmed not to activate the patient interface system if it measures a weight below or above certain set weights or not to send measurements to the remote monitoring if it measures a weight below or above certain set weights.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: June 27, 2000
    Assignee: Alere Incorporated
    Inventors: Lester John Lloyd, Melissa Ann Prince
  • Patent number: 6077222
    Abstract: Methods and devices are provided for detecting the presence of edema in a mammalian host. In the subject methods, at least one limbic extremity of the host, preferably a lower limbic extremity such as an ankle or foot, is introduced into a container of a displaceable medium to result in displacement of a portion of the medium. The displaced portion is measured and the measured value is then compared to a control value to identify any difference. The difference is then related to the presence of edema in the patient. The subject methods find use in the diagnosis and management of diseases characterized by the presence of edema as a physical manifestation, particularly congestive heart failure.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: June 20, 2000
    Assignee: Alere Incorporated
    Inventors: Lester John Lloyd, Jorah Wyer
  • Patent number: 6014969
    Abstract: A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: January 18, 2000
    Assignee: Aradigm Corporation
    Inventors: Lester John Lloyd, Peter M. Lloyd, Reid M. Rubsamen, Jeffrey Arthur Schuster
  • Patent number: 5957867
    Abstract: Methods and devices are provided for detecting the presence of edema in a mammalian host. In the subject methods, a device comprising a planar surface and a probe extendable therefrom is contacted with the surface of the extremity. The probe is then extended from the planar surface in a manner sufficient to form a depression or "pit" in the skin surface of the extremity. The probe is then held in constant position relative to the planar surface and the extremity for a period of time during which a plurality of force measurements and a force profile is generated therefrom. The force profile is then related to the presence of edema in the patient. The subject methods find use in the diagnosis and management of diseases characterized by the presence of edema as a physical manifestation, particularly congestive heart failure.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: September 28, 1999
    Assignee: Alere Incorporated
    Inventors: Lester John Lloyd, Jorah Wyer